Keyphrases
Anti-vascular Endothelial Growth Factor (anti-VEGF)
33%
CI Confidence Interval
16%
Clinical Characteristics
100%
Clinical Features
16%
Endemic Region
16%
Epidemiological Characteristics
100%
Epidemiology
16%
Histoplasmosis
16%
Incidence Characteristics
16%
Incidence Prevalence
16%
Incidence Rate
33%
Incident Cases
16%
International Classification of Disease Codes
16%
International Classification of Diseases, 10th Revision
16%
International Classification of Diseases, 9th Revision
16%
Linkage System
16%
Medical Care
16%
Medical Records
16%
Midwestern US
16%
Minnesota
100%
Myopic Choroidal Neovascularization (mCNV)
50%
Ocular Histoplasmosis
100%
Olmsted County
100%
Presumed Ocular Histoplasmosis Syndrome
100%
Prevalence Characteristics
16%
Prevalence Rate
16%
Prevalent Cases
16%
Record Linkage
16%
Rochester Epidemiology Project
33%
Syndrome Diagnosis
16%
U.S. Counties
16%
Visual Acuity
33%
White Population
16%
Medicine and Dentistry
Choroidal Neovascularization
50%
Clinical Feature
16%
Cohort Effect
100%
Gene Linkage
16%
ICD-10
16%
ICD-9
16%
International Classification of Diseases
16%
Medical Care
16%
Medical Record
16%
Ocular Histoplasmosis
100%
Presumed Ocular Histoplasmosis Syndrome
100%
Prevalence
33%
Vasculotropin
33%
Visual Acuity
33%
White Population
16%
Nursing and Health Professions
Clinical Feature
14%
Confidence Interval
14%
ICD-10
14%
ICD-9
14%
International Classification of Diseases
14%
Medical Care
14%
Medical Record
14%
Nomenclature
14%
Ocular Histoplasmosis
100%
Prevalence
28%
Subretinal Neovascularization
42%
Vasculotropin
28%
Visual Acuity
28%
White Population
14%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Feature
14%
Histoplasma
14%
ICD-10
14%
ICD-9
14%
International Classification of Diseases
14%
Ocular Histoplasmosis
100%
Prevalence
28%
Subretinal Neovascularization
42%
Vasculotropin
28%